Latest Health News
World Neglected Tropical Diseases Day 2026: Unite, Act, Eliminate
Observed on January 30, this day raises awareness for NTDs affecting over one billion people, with 58 countries eliminating at least one NTD as of early 2026. Progress includes 9 countries validated in 2025 for eliminations like trachoma and sleeping sickness, but challenges persist from 41% funding decline since 2018, climate change, and conflicts.
New Brain Tumor Clinical Trial for Glioblastoma Using Focused Ultrasound
Taiwanese researchers completed an early-stage trial showing focused ultrasound with chemotherapy is safe for GBM patients using the NaviFUS system and are now recruiting for a larger trial. Advances in brain targeting also improve treatments for essential tremor and Parkinson's.
FDA Clears Noninvasive Kidney Stone Treatment Device
SonoMotion’s Break Wave™ lithotripsy system received FDA clearance for treating kidney stones without anesthesia or stents, performable at various care sites. This marks a significant advancement in noninvasive urology procedures.
Climate-Driven Extreme Weather Threatens Malaria Control in Africa
A Nature study projects over 100 million additional malaria cases in Africa by 2050 due to extreme weather disrupting prevention and healthcare, not just mosquito ecology. This underscores needs for global funding and adaptation strategies.
Breakthrough Sepsis Drug STC3141 Succeeds in Phase II Trial
Australian-developed carbohydrate-based drug STC3141 reduced sepsis severity in a 180-patient trial by calming dangerous immune reactions leading to organ failure. Grand Pharma plans Phase III trials, potentially saving millions of lives soon.
Two Confirmed Nipah Virus Cases Reported in India
India notified WHO of two lab-confirmed NiV infections in West Bengal on January 26, 2026, confirmed by the National Institute of Virology. NiV is a highly lethal zoonotic virus requiring urgent public health response.
Verrica Pharmaceuticals Starts Phase 3 Trials for Common Warts Treatment
VP-102 advances in Phase 3 to address unmet needs in common warts treatment. Multiple dermatology firms like Legacy and MoonLake report progress in alopecia areata and hidradenitis suppurativa therapies.
Alpha Tau Advances Novel Therapy for Cutaneous Squamous Cell Carcinoma
Alpha DaRT offers localized treatment for recurrent cSCC with minimal toxicity. Quoin seeks Breakthrough Designation for QRX003, first potential therapy for Netherton Syndrome.
FDA Grants Breakthrough Designation to Alixorexton for Narcolepsy Type 1
Alkermes’ oral orexin 2 receptor agonist alixorexton receives designation based on Phase 2 data from 92 NT1 patients. It targets NT1, NT2, and idiopathic hypersomnia.
FDA Approves ProlivRx: First At-Home Neuromodulation for Major Depressive Disorder
Neurolief’s ProlivRx, approved via Class III pathway, aids MDD patients unresponsive to antidepressants based on MOOD Study results. Cognition Therapeutics reports positive Phase 2 for zervimesine in dementia with Lewy bodies.
PATINA Trial: Palbociclib Improves Survival in HR+/HER2+ Metastatic Breast Cancer
Adding CDK4/6 inhibitor palbociclib to maintenance therapy significantly boosts progression-free survival, changing standard care per NEJM publication. ECOG-ACRIN highlights 2025 advances in breast, leukemia, lung cancers, melanoma.
Spanish Scientists Cure Pancreatic Cancer in Mice with Triple Therapy
Researchers used triple therapy to cure pancreatic cancer in mice, published in a scientific journal, offering hope for human applications. This breakthrough targets one of the deadliest cancers.